Literature DB >> 18782813

The effect of paraproteins on the erythrocyte sedimentation rate: a comparison between the StarrSed and TEST 1.

Maarten T M Raijmakers1, Philip H M Kuijper, Dirk L Bakkeren, Huib L Vader.   

Abstract

BACKGROUND: The principle of the erythrocyte sedimentation rate (ESR) as assessed by TEST 1 is different from that of Westergren-based methods. This could result in different influences on the tests by paraproteins.
METHODS: We investigated the effect of paraproteins on ESR readings by TEST 1 (y) and the StarrSed (x), a Westergren-based method, in 142 patients with paraproteinaemia. Agreement (Passing-Bablok) and bias (Bland-Altman) between methods was investigated and compared with that of a control population.
RESULTS: A poor agreement between the two methods was found in patients with a paraprotein (y = 0.67x + 3.3) in comparison with that of the control population (y = 0.96x + 0.2). Large differences between methods were present when ESR readings were >40 mm/hour, but clinical interpretation was similar in 90% of cases. Linear regression showed a concentration dependent influence of paraproteins on ESR readings by the StarrSed, especially for immunoglobulin class IgM.
CONCLUSION: ESR readings by TEST 1 result in similar clinical interpretation for most subjects, but readings are less influenced by the presence of a paraprotein than those of a Westergren-based method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18782813     DOI: 10.1258/acb.2008.008062

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  1 in total

1.  Validity and Agreement between the 28-Joint Disease Activity Score Based on C-Reactive Protein and Erythrocyte Sedimentation Rate in Patients with Rheumatoid Arthritis.

Authors:  Louise Nielung; Robin Christensen; Bente Danneskiold-Samsøe; Henning Bliddal; Christian Cato Holm; Karen Ellegaard; Hanne Slott Jensen; Else Marie Bartels
Journal:  Arthritis       Date:  2015-01-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.